Skip to main content
Clinical Trials/DRKS00027287
DRKS00027287Completed未知

Hemadsorption through supportive establishment of an Oxiris® filter in septic shock with suspected cytokine release syndrome - a randomized controlled intervention study - HEMOXISE- HEMoadsorption with OXIris in Septic shock with cytocinE storm- a randomized controlled trial

Klinik für Anästhesiologie Universitätsklinikum Heidelberg0 sites19 target enrollmentStarted: January 24, 2022Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
19

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomized controlled study
Masking
Open (masking not used)

Eligibility Criteria

Ages
18 Years to one (—)
Sex
All

Inclusion Criteria

  • Written declaration of consent by the study participant or his legally appointed representative
  • - Age = 18 years
  • - Suspected infection
  • - Furthermore, the criteria of septic shock according to the sepsis 3 definition must be met:
  • - Suspected infection (see above)
  • - SOFA score = 2
  • - Vasopressor requirement to maintain adequate hemodynamics (MAP = 65 mmHg), despite sufficient fluid resuscitation
  • - Serum lactate > 2 mmol / l
  • - In addition, there must be suspicion of a cytokine release syndrome, determined with a Point of Care IL-6 test (Milena® Quick Line IL-6 test). Defined as:
  • IL -6 > 300 pg / ml
  • - Furthermore, indications for a renal replacement therapy (RRT) must be met, according to the following absolute or relative criteria:
  • Absolute criteria: Critical ill patient and one of the following:
  • - Blood urea nitrogen > 200 mg/dl
  • - Potassium > 5.8 mmol/l
  • - urine excretion < 0.3 ml/kg/h > 6 hrs and refractary pulmonary fluid overload, formation/worsening of a pulmonary edema (defined as bilateral infiltrations with a PaO2/FIO2 < 300 mmHg and/or positive fluid balance > 10% of admission weight)
  • relative criteria: critical ill patient with acute kidney injury KDIGO 2 or 3 and fullfillment of all three of the following:
  • 1. septic shock
  • 2. age 18-90 years
  • 3. full critical care support planned for at least 3 days

Exclusion Criteria

  • - Not meeting inclusion criteria
  • - Patient refusal
  • - Technically imposssible to conduct renal replacement therapy
  • - Preexisting congestive heart failure, defined as New York Heart Association Klassifikation = II and/or a preexisting left ventricular ejection fraction of < 40%
  • - Heparin allergy or contraindications against heparin use
  • - Suspicion of or confirmed heparin induced thrombocytopenia
  • - Pregnancy
  • - Inclusion in another interventional study
  • - Iatrogenic immunsuppression

Investigators

Sponsor
Klinik für Anästhesiologie Universitätsklinikum Heidelberg

Similar Trials

Completed
Not Applicable
The effect of haemoadsorption in relation to the cytokine concentration during cardiothoracic surgery procedures while using extracorporeal circulation.Produktie van cytokine door het lichaam tijdens open hartchirurgie.Cytokine productionInflammatory reactions10011082
NL-OMON45517Medisch Centrum Leeuwarden30
Active, not recruiting
Phase 1
Scavenging free haemoglobin atenuates the systemic inflmmatory response following surgerySystemic inflammatory response and associated multiorgan failure that follows cardiopulmonary bypass for cardiac surgeryMedDRA version: 9.1Level: LLTClassification code 10062357Term: SIRSMedDRA version: 9.1Level: LLTClassification code 10066123Term: Cardiopulmonary bypassMedDRA version: 9.1Level: LLTClassification code 10018910Term: HaemolysisMedDRA version: 9.1Level: LLTClassification code 10027803Term: MOF
EUCTR2007-004856-35-GBImperial College London540
Completed
Not Applicable
Staple-line bleeding reduction using a bioabsorbable reinforcement in day surgery stapled hemorrhoidopexySymptomatic II-III grade haemorrhoids and rectal mucosal prolapseUrological and Genital Diseases
ISRCTN33808948a Sapienza University of Rome (Italy)70
Completed
Not Applicable
A study to investigate systemic absorption of health food: a cross over studyone
JPRN-UMIN000028354CROee.INC7
Recruiting
Unknown
Direct hemoperfusion with PMMA to adsorb uremic toxins in hemodialysis patientsChronic kidney disease undergoing hemodialysisDialysis-related amyloidosisDialysis-related amyloidosis, choronic kidney disease
JPRN-jRCT1032230028Yamamoto Suguru10